Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03363711 · ClinicalTrials.gov registry record
AYA STEPS RCT: AYA Self-Management Via Texting, Education & Plans for Survivors
A clinical trial of Adolescent and Young Adult (AYA) Cancer Survivors, sponsored by Abramson Cancer Center at Penn Medicine.
- Active
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT03363711: Active study of Adolescent and Young Adult (AYA) Cancer Survivors, sponsored by Abramson Cancer Center at Penn Medicine.
NCT03363711 is a study of Adolescent and Young Adult (AYA) Cancer Survivors that is active but no longer recruiting, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03363711, a study of Adolescent and Young Adult (AYA) Cancer Survivors, is active but no longer recruiting, sponsored by Abramson Cancer Center at Penn Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed project will leverage two programs of research at UPenn and CHOP that are delivering technology-based interventions to adolescent and young adult (AYA) cancer survivors. In the proposed study, all AYA survivors will receive a care plan via a tool (Smart-ALACC). They will then be randomized to receive (or not) a mobile health application (AYA STEPS) that will provide tailored messages to enhance uptake of their care plan.
Conditions Studied
Interventions
- OTHER AYA STEPS
Study Locations (1)
Pennsylvania
- Abramson Cancer Center of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT03363711 still lists
NCT03363711 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 1 condition, with Adolescent and Young Adult (AYA) Cancer Survivors appearing as the primary indexed condition, and to 1 intervention - of which AYA STEPS is the first listed.
NCT03363711 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03363711 about?
NCT03363711 is a clinical study titled "AYA STEPS RCT: AYA Self-Management Via Texting, Education & Plans for Survivors". The proposed project will leverage two programs of research at UPenn and CHOP that are delivering technology-based interventions to adolescent and young adult (AYA) cancer survivors. In the proposed study, all AYA survivors will receive a care plan via a tool (Smart-ALACC). They will then be random...
What is the current status of trial NCT03363711?
This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2017-03-01. Estimated completion is 2026-12-31.
What conditions does trial NCT03363711 study?
This clinical trial studies the following conditions: Adolescent and Young Adult (AYA) Cancer Survivors.
What interventions are being tested in trial NCT03363711?
The interventions under investigation include: AYA STEPS (OTHER).
Who is sponsoring clinical trial NCT03363711?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03363711 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI